Gross Law Firm Announces Class Actions on Behalf of Shareholders of QFIN, ARDX and SLQT
NEW YORK, NY / ACCESSWIRE / August 27, 2021 / The Securities Litigation Law Firm of The Gross Law Firm is issuing the following opinion on behalf of the shareholders of the following publicly traded companies. Shareholders who have purchased shares in the following companies during the dates indicated are encouraged to contact the company regarding a possible principal applicant appointment. Appointment as principal applicant is not necessary to participate in any recovery.
360 DigiTech, Inc. (NASDAQ: QFIN)
Investors concerned: April 29, 2021 – July 7, 2021
A class action lawsuit has been brought on behalf of certain shareholders of 360 DigiTech, Inc. The complaint filed alleges that the defendants made materially false and / or misleading statements and / or failed to disclose that: (i) the Company collected personal information in violation of relevant laws and regulations of the People’s Republic of China; (ii) as a result, 360 DigiTech has been exposed to increased risk of regulatory oversight and / or enforcement actions; and (iii) accordingly, the Company’s public statements were materially false and misleading at all material times.
Shareholders can find more information at https://securitiesclasslaw.com/securities/360-digitech-inc-loss-submission-form/?id=19047&from=1
Ardelyx, Inc. (NASDAQ: ARDX)
Investors concerned: August 6, 2020 – July 19, 2021
A class action lawsuit has been brought on behalf of certain shareholders of Ardelyx, Inc. The filed complaint alleges that the defendants made materially false and / or misleading statements and / or failed to disclose that: 1) the company overestimated the likelihood of tenapanor being approved by the Food and Drug Administration (“FDA”); and 2) the defendants possessed, controlled and, therefore, knew that the data submitted to support the new drug application were insufficient in that they showed a lack of clinical relevance of the therapeutic effect of the drug. which makes it likely that the FDA would not approve the drug.
Shareholders can find more information at https://securitiesclasslaw.com/securities/ardelyx-inc-loss-submission-form/?id=19047&from=1
Selectquote, Inc. (NYSE: SLQT)
Investors concerned: February 8, 2021 – May 11, 2021
A class action lawsuit has been brought on behalf of certain shareholders of Selectquote, Inc. The complaint filed alleges that the defendants made materially false and / or misleading statements and / or failed to disclose that: (1) the 2019 cohort of SelectQuote was underperforming; (2) consequently, the financial results of the Company would be adversely affected; and (3) as a result of the foregoing, the Defendants’ positive statements regarding the business, operations and prospects of the Company were substantially misleading and / or lacked reasonable basis.
Shareholders can find more information at https://securitiesclasslaw.com/securities/selectquote-inc-loss-submission-form/?id=19047&from=1
The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The company seeks redress on behalf of investors who have suffered losses when false and / or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s shares. Lawyer advertising. Past results do not guarantee similar results.
The gross law firm
15 West 38th Street, 12th Floor
New York, New York, 10018
Email: [email protected]
Telephone: (212) 537-9430
Fax: (833) 862-7770
THE SOURCE: The Gross Law Firm
See the source version on accesswire.com: